Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

This entry notes an early-phase clinical trial investigating intermittent androgen deprivation therapy for Stage IV castration-sensitive prostate cancer, sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer, Stage IV Prostate Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING